# FDA Inspection 996030 - Glenmark Pharmaceuticals Inc., USA - December 05, 2016

Source: https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-inc-usa/c9d27d80-8970-4d16-9ee8-6df079067459
Source feed: FDA_Inspections

> FDA Inspection 996030 for Glenmark Pharmaceuticals Inc., USA on December 05, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 996030
- Company Name: Glenmark Pharmaceuticals Inc., USA
- Inspection Date: 2016-12-05
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 743660 - 2011-09-09](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-inc-usa/4012eb3f-d823-49b5-bc14-eaf7a0b2940d)
- [FDA Inspection 669685 - 2010-06-29](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-inc-usa/b98c41fe-947f-4d32-b8b3-d53ef954010a)

Company: https://www.keypedia.com/companies/glenmark-pharmaceuticals-inc-usa/a6863099-84a2-4d3f-b3e7-ed7c8ef8abf9

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c